These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378 [TBL] [Abstract][Full Text] [Related]
43. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [TBL] [Abstract][Full Text] [Related]
45. Comparison of MPTP and amphetamines as dopaminergic neurotoxins. Fuller RW Ann N Y Acad Sci; 1992 May; 648():87-95. PubMed ID: 1637075 [No Abstract] [Full Text] [Related]
46. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice. Khan HA Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308 [TBL] [Abstract][Full Text] [Related]
47. Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. Quik M; Chen L; Parameswaran N; Xie X; Langston JW; McCallum SE J Neurosci; 2006 Apr; 26(17):4681-9. PubMed ID: 16641249 [TBL] [Abstract][Full Text] [Related]
48. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions. Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176 [TBL] [Abstract][Full Text] [Related]
49. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Zuddas A; Fascetti F; Corsini GU; Piccardi MP Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437 [TBL] [Abstract][Full Text] [Related]
50. Cold water stress attenuates dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Xia M; Bian M; Yu Q; Liu J; Huang Y; Jin X; Lu S; Yu M; Huang F Acta Biochim Biophys Sin (Shanghai); 2011 Jun; 43(6):448-54. PubMed ID: 21558280 [TBL] [Abstract][Full Text] [Related]
51. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Gilad GM; Gilad VH; Finberg JP; Rabey JM Neurochem Res; 2005; 30(6-7):713-9. PubMed ID: 16187208 [TBL] [Abstract][Full Text] [Related]
52. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033 [TBL] [Abstract][Full Text] [Related]
53. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483 [TBL] [Abstract][Full Text] [Related]
54. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice. Wiener HL; Hashim A; Lajtha A; Sershen H J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936 [TBL] [Abstract][Full Text] [Related]
55. Dopamine agonist 3-PPP fails to protect against MPTP-induced toxicity. Muralikrishnan D; Ebadi M; Brown-Borg HM Neurochem Res; 2004 Feb; 29(2):379-84. PubMed ID: 15002733 [TBL] [Abstract][Full Text] [Related]
56. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice. Tabatabaei A; Perry TL; Hansen S; Krieger C Neurosci Lett; 1992 Jul; 141(2):192-4. PubMed ID: 1436633 [TBL] [Abstract][Full Text] [Related]
57. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163 [TBL] [Abstract][Full Text] [Related]
58. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment. Schneider JS; DiStefano L Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995 [TBL] [Abstract][Full Text] [Related]
59. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. Gainetdinov RR; Fumagalli F; Jones SR; Caron MG J Neurochem; 1997 Sep; 69(3):1322-5. PubMed ID: 9282960 [TBL] [Abstract][Full Text] [Related]
60. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]